NewGenIvf Group Ltd
NIVF2.390USD
+1.990+497.20%
Market hours （ET）Quotes delayed by 15 min
272.11KMarket Cap
LossP/E TTM
More Details of NewGenIvf Group Ltd Company
NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The Company offers services, such as Mitochondrial Replacement Therapy In Reproductive, Intrauterine Insemination (IUI), Mitochondrial replacement therapy (MRT) techniques, In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), semen analysis, testicular / epididymal sperm aspiration or extraction / percutaneous epididymal sperm aspiration, embryo transfer, chromosome screening and egg freezing. The Company’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. MRT involves an additional egg from a third person, and manipulating both the recipient egg and the donor egg.
Company Info
Ticker SymbolNIVF
Company nameNewGenIvf Group Ltd
IPO dateFeb 15, 2022
CEOMr. Claudius Tsang
Number of employees76
Security typeOrdinary Share
Fiscal year-endFeb 15
AddressLevel 39, Marina Bay Financial Centre
City
Stock exchangeNASDAQ Capital Market Consolidated
CountrySingapore
Postal code018983
Phone6568185796
Websitehttps://newgenivf.com/
Ticker SymbolNIVF
IPO dateFeb 15, 2022
CEOMr. Claudius Tsang
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Claudius Tsang
Mr. Claudius Tsang
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
--
--
Mr. Abuzzal Abusaeri
Mr. Abuzzal Abusaeri
Independent Director
Independent Director
--
--
Mr. John Brebeck
Mr. John Brebeck
Independent Director
Independent Director
--
--
Mr. Giang Nguyen Hoang
Mr. Giang Nguyen Hoang
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Claudius Tsang
Mr. Claudius Tsang
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
Chairman of the Board, Chief Executive Officer, Chief Financial Officer
--
--
Mr. Abuzzal Abusaeri
Mr. Abuzzal Abusaeri
Independent Director
Independent Director
--
--
Mr. John Brebeck
Mr. John Brebeck
Independent Director
Independent Director
--
--
Mr. Giang Nguyen Hoang
Mr. Giang Nguyen Hoang
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2024
FY2024Q4
FY2024Q3
FY2023
By BusinessUSD
Name
Revenue
Proportion
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
By RegionUSD
Name
Revenue
Proportion
Kyrgyzstan
2.66M
48.89%
Thailand
2.18M
40.04%
Cambodia
601.53K
11.07%
HK SAR
0.00
0.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
IVF treatment service
5.43M
0.00%
Surrogacy, ancillary caring and other services
0.00
0.00%
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
JAK Opportunities VI LLC
0.80%
Fong (Wai Lam Tina)
0.13%
Siu (Wing Fung Alfred)
0.10%
Chardan Capital Markets, LLC
0.09%
ATW Spac Management LLC
0.06%
Other
98.83%
Shareholders
Shareholders
Proportion
JAK Opportunities VI LLC
0.80%
Fong (Wai Lam Tina)
0.13%
Siu (Wing Fung Alfred)
0.10%
Chardan Capital Markets, LLC
0.09%
ATW Spac Management LLC
0.06%
Other
98.83%
Shareholder Types
Shareholders
Proportion
Corporation
0.80%
Individual Investor
0.25%
Research Firm
0.12%
Investment Advisor
0.06%
Venture Capital
0.05%
Hedge Fund
0.03%
Other
98.69%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
46
119.76K
1.31%
+103.93K
2025Q1
47
53.83K
2.05%
+29.38K
2024Q4
57
480.38K
3.57%
+160.77K
2024Q3
54
388.28K
4.20%
+63.85K
2024Q2
55
392.14K
4.96%
+40.32K
2024Q1
48
150.75K
80.91%
-221.01K
2023Q4
49
198.33K
101.36%
-231.83K
2023Q3
47
276.28K
99.62%
-143.70K
2023Q2
45
281.16K
89.44%
-138.41K
2023Q1
44
280.74K
89.29%
-146.12K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
JAK Opportunities VI LLC
72.95K
1.7%
+72.95K
--
Apr 20, 2025
Fong (Wai Lam Tina)
11.63K
0.27%
+11.63K
--
Apr 03, 2024
Siu (Wing Fung Alfred)
8.90K
0.21%
+8.90K
--
Apr 03, 2024
Chardan Capital Markets, LLC
7.84K
0.18%
+7.84K
--
Apr 03, 2024
ATW Spac Management LLC
5.63K
0.13%
+5.63K
--
Oct 04, 2024
White Lion Capital LLC
3.50K
0.08%
+3.50K
--
Nov 21, 2024
Sze (Kit Yee)
2.73K
0.06%
+2.73K
--
Apr 03, 2024
Virtu Americas LLC
2.70K
0.06%
+2.70K
--
Mar 31, 2025
Citadel Advisors LLC
2.48K
0.06%
+2.48K
--
Mar 31, 2025
XTX Markets LLC
1.13K
0.03%
+758.00
+205.42%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Date
Type
Ratio
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
Jan 31, 2025
Merger
20<1
